S. Subramanian
CFO, Aurobindo Pharma Limited
Notable Quotes
We have achieved excellent overall performance across business during FY 2025. With focused approach and right strategies in place, we are confident to continue our growth trajectory.
We are on track to achieve the 20%+ EBITDA margin target set internally for the year.